Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Red Light HollandTRUFF -0.46% Peter Lynch Fair Value is $0.01 as of Jul. 24, 2026, which is 99% below its 10-year median of 1.75. The stock has 4 warning signs investors should review. Among 264 Drug Manufacturers companies, Red Light Holland ranks better than 74.62% on this metric.
Peter Lynch Fair Value applies to growing companies. The ideal range for the growth rate is between 10 - 20% a year. Peter Lynch thinks that the fair P/E value for a growth company equals its growth rate, that is PEG = 1. The earnings here is trailing twelve month (TTM) earnings. For non-bank companies, the growth rate we use is the average growth rate for EBITDA per share over the past 5 years. For Banks, the growth rate we use is the average growth rate for Book Value per share over the past 5 years. If 5-Year Growth Rate is greater than 25% a year, we use 25. If 5-Year Growth Rate is smaller than 5% a year, we do not calculate Peter Lynch Fair Value.
Here, as of today, Red Light Holland's PEG is 1. Red Light Holland's 5-Year TTM EBITDA Growth Rate is 14.24.
Red Light Holland's EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2025 was $0.00. Therefore, the Peter Lynch Fair Value for today is $0.01.
As of today (2026-07-24), Red Light Holland's share price is $0.0218. Red Light Holland's Peter Lynch fair value is $0.01. Therefore, Red Light Holland's Price to Peter Lynch Fair Value Ratio for today is 1.53.
The historical rank and industry rank for Red Light Holland's Peter Lynch Fair Value or its related term are showing as below:
TRUFF'
s Price-to-Peter-Lynch-Fair-Value Range Over the Past 10 Years
Min: 0.5 Med: 1.75 Max: 3
Current: 0.73
During the past 7 years, the highest Price to Peter Lynch Fair Value Ratio of Red Light Holland was 3.00. The lowest was 0.50. And the median was 1.75.
TRUFF's Price-to-Peter-Lynch-Fair-Value is ranked better than 74.62% of 264
companies
in the Drug Manufacturers industry
Industry Median: 1.235
vs TRUFF: 0.73
Note: Please don't confuse Peter Lynch Fair Value with the value reached in Peter Lynch Chart.
Red Light Holland (OTCPK:TRUFF) Peter Lynch Fair Value Explanation
Peter Lynch Fair Value applies to growing companies. The ideal range for the growth rate is between 10 - 20% a year.
Peter Lynch thinks that the fair P/E value for a growth company equals its growth rate, that is PEG = 1. The earnings here is trailing twelve month (TTM) earnings. For non-bank companies, the growth rate we use is the average growth rate for EBITDA per share over the past 5 years. For Banks, the growth rate we use is the average growth rate for Book Value per share over the past 5 years.
Please don't confuse Peter Lynch Fair Value with the value reached in Peter Lynch Chart. In Peter Lynch chart, a fixed P/E ratio of 15 is used to draw the Earnings Line. Therefore the value reached has a P/E ratio of 15. But in Peter Lynch Fair Value calculation, P/E equals to the growth rate of EBITDA per share over the past 5 years, which is 14.24 instead of 15 in this case.
Red Light Holland's Price to Peter Lynch Fair Value Ratio for today is calculated as
Price to Peter Lynch Fair Value
=
Share Price
/
Peter Lynch Fair Value
=
0.0218
/
0.01
=
1.53
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Red Light Holland Peter Lynch Fair Value Related Terms
Red Light Holland Peter Lynch Fair Value Historical Data
* Premium members only.
The historical data trend for Red Light Holland's Peter Lynch Fair Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TRUFF vs ZTS, UTHR: Peter Lynch Fair Value Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Red Light Holland's Price-to-Peter-Lynch-Fair-Value, along with its competitors' market caps and Price-to-Peter-Lynch-Fair-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Red Light Holland Price-to-Peter-Lynch-Fair-Value vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Red Light Holland's Price-to-Peter-Lynch-Fair-Value distribution charts can be found below:
* The bar in red indicates where Red Light Holland's Price-to-Peter-Lynch-Fair-Value falls into.
Red Light Holland's EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Please be aware that the 5-Year TTM EBITDA Growth Rate is calculated based on TTM data over the last 5 years. For quarterly reported companies, the TTM data adds up the quarterly data reported by the company within the most recent 12 months. For companies that report semi-annually, annually, or do not have enough quarterly data, GuruFocus uses the annual data as the TTM data.
If 5-Year Earnings Growth Rate is greater than 25% a year, we use 25.
If 5-Year Earnings Growth Rate is smaller than 5% a year, we do not calculate Peter Lynch Fair Value.
Please note that we use the 5-year average growth rate of EBITDA per share as the growth rate for non-bank companies, as EBITDA growth is subject to less manipulations than net earnings per share. For banks, we use the 5-year average growth rate of Book Value per share as the growth rate. The reason is that EBITDA is not applicable to Banks and Book value is a relative important measurement for Banks. In the calculation, PEG=1 because Peter Lynch thinks that the fair P/E ratio of the growth stock is equal to its earnings growth rate.
Red Light Holland (TRUFF) has a Peter Lynch Fair Value of $0.01 as of Jul. 24, 2026. Peter Lynch Fair Value is the stock value based on a company's current earnings and five-year earnings growth, assuming a PEG of one. View historical data on Red Light Holland and its competitors. This is 99% below median its historical median of 1.75. Over the past decade, Red Light Holland's Peter Lynch Fair Value has ranged from 0.50 to 3.00. According to the industry distribution chart, Red Light Holland ranks #67 out of 264 companies in the Drug Manufacturers industry, placing it in the top 25.4%.
Is Red Light Holland's Peter Lynch Fair Value too high?
Red Light Holland's current Peter Lynch Fair Value of $0.01 is 99% below median its 10-year median of 1.75. Over the past 10 years, this metric has ranged from a low of 0.50 to a high of 3.00. The Drug Manufacturers industry median Peter Lynch Fair Value is 1.24. Red Light Holland's value of $0.01 is 99.2% below this industry median. Based on the distribution chart, Red Light Holland ranks #67 out of 264 companies in the Drug Manufacturers industry, which is above the industry midpoint.
How does Red Light Holland's Peter Lynch Fair Value compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Red Light Holland ranks #67 out of 264 companies for Peter Lynch Fair Value. This puts Red Light Holland in the upper half of its industry. The industry median Peter Lynch Fair Value is 1.24. Red Light Holland's value of $0.01 is 99.2% below this benchmark. Historically, Red Light Holland's own Peter Lynch Fair Value has ranged from 0.50 to 3.00 over the past decade. While the company's 10-year median is 1.75 vs. the industry median of 1.24, Red Light Holland has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Peter Lynch Fair Value for a Drug Manufacturers company?
The median Peter Lynch Fair Value among Drug Manufacturers companies is 1.24, based on 264 companies in the industry. Companies in the top quartile (top 25%) have a Peter Lynch Fair Value significantly above this median, while those in the bottom quartile fall well below. However, Peter Lynch Fair Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Red Light Holland's current Peter Lynch Fair Value of $0.01 is 99.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Peter Lynch Fair Value mean?
A high Peter Lynch Fair Value can signal that a stock is expensive relative to its fundamentals. Peter Lynch Fair Value is the stock value based on a company's current earnings and five-year earnings growth, assuming a PEG of one. View historical data on Red Light Holland and its competitors. For the Drug Manufacturers industry, the median Peter Lynch Fair Value is 1.24 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Red Light Holland's current Peter Lynch Fair Value is $0.01, which is 99% below median its own 10-year median of 1.75. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Red Light Holland stock overvalued right now?
Based on GuruFocus' analysis, Red Light Holland (TRUFF) is currently considered Modestly Undervalued. The stock's GF Value™ is $0.03, compared to a current price of $0.02 — trading 27.3% below its estimated fair value. The current Peter Lynch Fair Value is $0.01, which is 99% below median its 10-year median of 1.75 and 99.2% below the Drug Manufacturers industry median of 1.24. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Peter Lynch Fair Value calculated?
Peter Lynch Fair Value is calculated from a company's financial statements. For Red Light Holland (TRUFF), the current Peter Lynch Fair Value is $0.01 as of Jul. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Red Light Holland Corp is engaged in the production, growth, and sale of functional mushrooms and mushroom home grow kits in North America and Europe, and a premium brand of psilocybin truffles to the legal, recreational market within the Netherlands. Its products include Microdosing Kit and Merch. Its revenue is comprised of sales of wholesale truffles, cannabis seeds, and other cannabis products and sales of microdose packs.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TRUFF has been successfully added to your 
